Search results
While new medicines are crucial to address untreated diseases, we prioritise adapting existing molecules into different formulations to improve ease of administration. Through a blend of patient insight, rigorous data analysis, and dedicated research, we evolve medicines to make them more manageable for patients.
At Colonis, we repurpose medicines to make them more manageable for patients. By identifying and understanding how unmet clinical needs impact patients, we develop innovative solutions that improve compliance and enhance health outcomes, empowering individuals to live their lives to the fullest.
Making Medicines More Manageable At Colonis, we repurpose medicines to make them more manageable for patients. By identifying and understanding how unmet clinical needs impact patients,...
Dec 15, 2023 · At Colonis, we harness our out-licensing partnerships to deliver high-quality, value-added medicines to new markets, certifying future growth and ensuring continued progress. The benefits of out-licensing. Out-licensing offers a host of advantages for pharmaceutical companies seeking a streamlined path to commercialisation in a new market.
Colonis Pharma is a company specializing in the development, regulatory approval, and commercialization of medicines that are currently unlicensed but have an existing patient need and prescriber demand. The company aims to make medicines more manageable for patients and healthcare professionals.
At Colonis, we repurpose medicines to make them more manageable for patients while prioritising their needs. By identifying unmet clinical needs, we have developed a portfolio of...
In addition to its unlicensed to licensed capabilities, Colonis is dedicated to making medicines more manageable for patients and healthcare professionals. www.colonis.co.uk
